Physical exercise prevents and mitigates non-alcoholic steatohepatitis-induced liver mitochondrial structural and bioenergetics impairments

Mitochondrion

Volumn 15, Issue 1, 2014, Pages 40-51

  Gonçalves, Inês O ^a   Passos, Emanuel ^b   Rocha Rodrigues, Silvia ^a   Diogo, Cátia V ^c   Torrella, Joan R ^d   Rizo, David ^d   Viscor, Ginés ^d   Santos Alves, Estela ^a   Marques Aleixo, Inês ^a   Oliveira, Paulo J ^c   Ascensão, António ^a   Magalhães, José ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

^d UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Hepatic; Mitochondria; NAFLD; Physical activity; Training

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CYTOCHROME C; MANGANESE SUPEROXIDE DISMUTASE; UNCOUPLING PROTEIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CONTROLLED STUDY; ENDURANCE TRAINING; ENZYME ACTIVITY; FATTY ACID OXIDATION; KINESIOTHERAPY; LIPID OXIDATION; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN METABOLISM; RAT; RESPIRATORY CHAIN; ANIMAL; DISEASE MODEL; ENERGY METABOLISM; FATTY LIVER, ALCOHOLIC; LIVER; MITOCHONDRION; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; ULTRASTRUCTURE;

ANIMALS; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FATTY LIVER, ALCOHOLIC; LIVER; MITOCHONDRIA; PHYSICAL CONDITIONING, ANIMAL; RATS, SPRAGUE-DAWLEY;

EID: 84899681057     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2014.03.012     Document Type: Article

References (67)

1. Abdelmegeed M.A., Yoo S.H., Henderson L.E., Gonzalez F.J., Woodcroft K.J., Song B.J. PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver. J. Nutr. 2011, 141:603-610.
2. Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., Ibrisim D., Gulluoglu M., Ozdil S., Besisik F., Kaymakoglu S., Boztas G., Cakaloglu Y., Mungan Z., Canberk Y., Okten A. Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis?. J. Gastroenterol. Hepatol. 2010, 25:619-626.
3. Aoun M., Fouret G., Michel F., Bonafos B., Ramos J., Cristol J.P., Carbonneau M.A., Coudray C., Feillet-Coudray C. Dietary fatty acids modulate liver mitochondrial cardiolipin content and its fatty acid composition in rats with non alcoholic fatty liver disease. J. Bioenerg. Biomembr. 2012, 44:439-452.
4. Ascensao A., Goncalves I.O., Lumini-Oliveira J., Marques-Aleixo I., Dos Passos E., Rocha-Rodrigues S., Machado N.G., Moreira A.C., Oliveira P.J., Torrella J.R., Magalhaes J. Endurance training and chronic intermittent hypoxia modulate in vitro salicylate-induced hepatic mitochondrial dysfunction. Mitochondrion 2012, 12:607-616.
5. Ascensao A., Martins M.J., Santos-Alves E., Goncalves I.O., Portincasa P., Oliveira P.J., Magalhaes J. Modulation of hepatic redox status and mitochondrial metabolism by exercise: therapeutic strategy for liver diseases. Mitochondrion 2013, 13:862-870.
6. Baffy G., Zhang C.Y., Glickman J.N., Lowell B.B. Obesity-related fatty liver is unchanged in mice deficient for mitochondrial uncoupling protein 2. Hepatology 2002, 753-761. (United States).
7. Begriche K., Igoudjil A., Pessayre D., Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006, 6:1-28.
8. Bellentani S., Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann. Hepatol. 2009, 8(Suppl. 1):S4-S8.
9. Bhat G., Baba C.S., Pandey A., Kumari N., Choudhuri G. Life style modification improves insulin resistance and liver histology in patients with non-alcoholic fatty liver disease. World J. Hepatol. 2012, 4:209-217.
10. Chavin K.D., Yang S., Lin H.Z., Chatham J., Chacko V.P., Hoek J.B., Walajtys-Rode E., Rashid A., Chen C.H., Huang C.C., Wu T.C., Lane M.D., Diehl A.M. Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion. J. Biol. Chem. 1999, 274:5692-5700.
11. Chiang D.J., Pritchard M.T., Nagy L.E. Obesity, diabetes mellitus, and liver fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, G697-G702. (United States).
12. Ciapaite J., van den Broek N.M., Te Brinke H., Nicolay K., Jeneson J.A., Houten S.M., Prompers J.J. Differential effects of short- and long-term high-fat diet feeding on hepatic fatty acid metabolism in rats. Biochim. Biophys. Acta 2011, 1811:441-451.
13. Clark J.M. The epidemiology of nonalcoholic fatty liver disease in adults. J. Clin. Gastroenterol. 2006, 40(Suppl. 1):S5-S10.
14. Coore H.G., Denton R.M., Martin B.R., Randle P.J. Regulation of adipose tissue pyruvate dehydrogenase by insulin and other hormones. Biochem. J. 1971, 125:115-127.
15. Cortez-Pinto H., Chatham J., Chacko V.P., Arnold C., Rashid A., Diehl A.M. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 1999, 282:1659-1664.
16. De Feo P. Is high-intensity exercise better than moderate-intensity exercise for weight loss?. Nutr Metab Cardiovasc Dis 2013, 23:1037-1042.
17. Estabrook R. Mitochondrial respiratory control and the polarographic measurement of ADP/O ratios. Methods Enzymol. 1967, 10:41-47.
18. Estrany M.E., Proenza A.M., Llado I., Gianotti M. Isocaloric intake of a high-fat diet modifies adiposity and lipid handling in a sex dependent manner in rats. Lipids Health Dis. 2011, 52. (England).
19. Evans Z.P., Ellett J.D., Schmidt M.G., Schnellmann R.G., Chavin K.D. Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion. J. Biol. Chem. 2008, 8573-8579. (United States).
20. Evans Z.P., Palanisamy A.P., Sutter A.G., Ellett J.D., Ramshesh V.K., Attaway H., Schmidt M.G., Schnellmann R.G., Chavin K.D. Mitochondrial uncoupling protein-2 deficiency protects steatotic mouse hepatocytes from hypoxia/reoxygenation. Am. J. Physiol. Gastrointest. Liver Physiol. 2012, G336-G342. (United States).
21. Fujita K., Nozaki Y., Wada K., Yoneda M., Fujimoto Y., Fujitake M., Endo H., Takahashi H., Inamori M., Kobayashi N., Kirikoshi H., Kubota K., Saito S., Nakajima A. Dysfunctional very-low-density lipoprotein synthesis and release is a key factor in nonalcoholic steatohepatitis pathogenesis. Hepatology 2009, 50:772-780.
22. Gonçalves I.O., Portincasa P., Grattagliano I., Pizarro A.N., Ascensão A., Magalhães J. Habitual physical activity and liver mitochondrial function in patients with non-alcoholic fatty liver disease (NAFLD). A pilot study. Eur. J. Clin. Invest. 2012, 42:80.
23. Goncalves I.O., Oliveira P.J., Ascensao A., Magalhaes J. Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis. Eur. J. Clin. Invest. 2013, 43:1184-1194.
24. Grattagliano I., Russmann S., Diogo C., Bonfrate L., Oliveira P.J., Wang D.Q., Portincasa P. Mitochondria in chronic liver disease. Curr. Drug Targets 2011, 12:879-893.
25. Grattagliano I., de Bari O., Bernardo T.C., Oliveira P.J., Wang D.Q., Portincasa P. Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation. Clin. Biochem. 2012, 45:610-618.
26. He Y., Zhang H., Fu F. The effects of swimming exercise on high-fat-diet-induced steatohepatitis. J. Sports Med. Phys. Fitness 2008, 48:259-265.
27. Hu M.-L. Measurement of protein thiol groups and GSH in plasma. Methods in Enzimology 1990, 380-385. Academic Press, San Diego. L. Parker (Ed.).
28. Iossa S., Lionetti L., Mollica M.P., Crescenzo R., Botta M., Barletta A., Liverini G. Effect of high-fat feeding on metabolic efficiency and mitochondrial oxidative capacity in adult rats. Br. J. Nutr. 2003, 90:953-960.
29. Jiang Y., Zhao M., An W. Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance. J. Mol. Med. (Berl.) 2011, 89:1207-1217.
30. Kamo N., Muratsugu M., Hongoh R., Kobatake Y. Membrane potential of mitochondria measured with an electrode sensitive to tetraphenyl phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J. Membr. Biol. 1979, 49:105-121.
31. Kistler K.D., Brunt E.M., Clark J.M., Diehl A.M., Sallis J.F., Schwimmer J.B. Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease. Am. J. Gastroenterol. 2011, 106:460-468. (quiz 469).
32. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., Ferrell L.D., Liu Y.C., Torbenson M.S., Unalp-Arida A., Yeh M., McCullough A.J., Sanyal A.J. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
33. Krebs H.A., Holzach O. The conversion of citrate into cis-aconitate and isocitrate in the presence of aconitase. Biochem. J. 1952, 52:527-528.
34. Kris-Etherton P.M., Taylor D.S., Zhao G. Is there an optimal diet for the hypertriglyceridemic patient?. J. Cardiovasc. Risk 2000, 7:333-337.
35. Kucera O., Garnol T., Lotkova H., Stankova P., Mazurova Y., Hroch M., Bolehovska R., Rousar T., Cervinkova Z. The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats. Physiol. Res. 2011, 317-328. (Czech Republic).
36. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
37. Laurent A., Nicco C., Tran Van Nhieu J., Borderie D., Chereau C., Conti F., Jaffray P., Soubrane O., Calmus Y., Weill B., Batteux F. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 2004, 39:1277-1285.
38. Li Z., Agellon L.B., Allen T.M., Umeda M., Jewell L., Mason A., Vance D.E. The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metab. 2006, 321-331. (United States).
39. Lieber C.S., Leo M.A., Mak K.M., Xu Y., Cao Q., Ren C., Ponomarenko A., DeCarli L.M. Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 2004, 79:502-509.
40. Locke M., Noble E.G., Atkinson B.G. Exercising mammals synthesize stress proteins. Am. J. Physiol. 1990, 258:C723-C729.
41. Mantena S.K., Vaughn D.P., Andringa K.K., Eccleston H.B., King A.L., Abrams G.A., Doeller J.E., Kraus D.W., Darley-Usmar V.M., Bailey S.M. High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem. J. 2009, 417:183-193.
42. Navarro A., Gomez C., Lopez-Cepero J.M., Boveris A. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, R505-R511. (United States).
43. Pejic R.N., Lee D.T. Hypertriglyceridemia. J. Am. Board Fam. Med. 2006, 19:310-316.
44. Perez-Carreras M., Del Hoyo P., Martin M.A., Rubio J.C., Martin A., Castellano G., Colina F., Arenas J., Solis-Herruzo J.A. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003, 999-1007. (United States).
45. Petrosillo G., Portincasa P., Grattagliano I., Casanova G., Matera M., Ruggiero F.M., Ferri D., Paradies G. Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim. Biophys. Acta 2007, 1767:1260-1267.
46. Promrat K., Kleiner D.E., Niemeier H.M., Jackvony E., Kearns M., Wands J.R., Fava J.L., Wing R.R. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010, 51:121-129.
47. Raffaella C., Francesca B., Italia F., Marina P., Giovanna L., Susanna I. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance. Obesity (Silver Spring) 2008, 16:958-964.
48. Rector R.S., Thyfault J.P., Laye M.J., Morris R.T., Borengasser S.J., Uptergrove G.M., Chakravarthy M.V., Booth F.W., Ibdah J.A. Cessation of daily exercise dramatically alters precursors of hepatic steatosis in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. J. Physiol. 2008, 586:4241-4249.
49. Rector R.S., Thyfault J.P., Morris R.T., Laye M.J., Borengasser S.J., Booth F.W., Ibdah J.A. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G619-G626.
50. Rector R.S., Uptergrove G.M., Morris E.M., Borengasser S.J., Laughlin M.H., Booth F.W., Thyfault J.P., Ibdah J.A. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 300:G874-G883.
51. Rodriguez G., Gallego S., Breidenassel C., Moreno L.A., Gottrand F. Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?. Nutr. Hosp. 2010, 25:712-717.
52. Rohn T.T., Hinds T.R., Vincenzi F.F. Ion transport ATPases as targets for free radical damage. Protection by an aminosteroid of the Ca2+ pump ATPase and Na+/K+pump ATPase of human red blood cell membranes. Biochem. Pharmacol. 1993, 46:525-534.
53. Rolo A.P., Teodoro J.S., Palmeira C.M. Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 2012, 52:59-69.
54. Serviddio G., Bellanti F., Vendemiale G., Altomare E. Mitochondrial dysfunction in nonalcoholic steatohepatitis. Expert Rev. Gastroenterol. Hepatol. 2011, 5:233-244.
55. Sreenivasa Baba C., Alexander G., Kalyani B., Pandey R., Rastogi S., Pandey A., Choudhuri G. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis. J. Gastroenterol. Hepatol. 2006, 21:191-198.
56. Sun L., Shen W., Liu Z., Guan S., Liu J., Ding S. Endurance exercise causes mitochondrial and oxidative stress in rat liver: effects of a combination of mitochondrial targeting nutrients. Life Sci. 2010, 86:39-44.
57. Taylor B.A., Phillips S.J. Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics 1996, 389-398. (United States).
58. Teodoro J., Rolo A.P., Oliveira P.J., Palmeira C.M. Decreased ANT content in Zucker fatty rats: relevance for altered hepatic mitochondrial bioenergetics in steatosis. FEBS Lett. 2006, 580:2153-2157.
59. Teodoro J., Rolo A.P., Duarte F.V., Simoes A.M., Palmeira C.M. Differential alterations in mitochondrial function induced by a choline-deficient diet: understanding fatty liver disease progression. Mitochondrion 2008, 8:367-376.
60. Thyfault J.P., Rector R.S., Uptergrove G.M., Borengasser S.J., Morris E.M., Wei Y., Laye M.J., Burant C.F., Qi N.R., Ridenhour S.E., Koch L.G., Britton S.L., Ibdah J.A. Rats selectively bred for low aerobic capacity have reduced hepatic mitochondrial oxidative capacity and susceptibility to hepatic steatosis and injury. J. Physiol. 2009, 587:1805-1816.
61. Van Norman K.H. The biuret reaction and the cold nitric acid test in the recognition of protein. Biochem. J. 1909, 4:127-135.
62. Vial G., Dubouchaud H., Couturier K., Cottet-Rousselle C., Taleux N., Athias A., Galinier A., Casteilla L., Leverve X.M. Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J. Hepatol. 2011, 54:348-356.
63. Volek J.S., Fernandez M.L., Feinman R.D., Phinney S.D. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog. Lipid Res. 2008, 47:307-318.
64. Wang Y., Ausman L.M., Russell R.M., Greenberg A.S., Wang X.D. Increased apoptosis in high-fat diet-induced nonalcoholic steatohepatitis in rats is associated with c-Jun NH2-terminal kinase activation and elevated proapoptotic Bax. J. Nutr. 2008, 138:1866-1871.
65. Wang Y., Ausman L.M., Greenberg A.S., Russell R.M., Wang X.D. Nonalcoholic steatohepatitis induced by a high-fat diet promotes diethylnitrosamine-initiated early hepatocarcinogenesis in rats. Int. J. Cancer 2009, 124:540-546.
66. Wierzbicki A.S., Clarke R.E., Viljoen A., Mikhailidis D.P. Triglycerides: a case for treatment?. Curr. Opin. Cardiol. 2012, 27:398-404.
67. Zhang L., Geng Y., Xiao N., Yin M., Mao L., Ren G., Zhang C., Liu P., Lu N., An L., Pan J. High dietary n-6/n-3 PUFA ratio promotes HDL cholesterol level, but does not suppress atherogenesis in apolipoprotein E-null mice 1. J. Atheroscler. Thromb. 2009, 463-471. (Japan).